NBS

NeoStem Announces Closing of Acquisition of California Stem Cell, Inc. and First Quarter 2014 Financial Results

[GlobeNewswire] – NEW YORK — NeoStem, Inc. (NeoStem or the Company), a leader in the emerging cellular therapy industry, today announced first quarter 2014 financial results as well as the closing … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here to view […]

NeoStem, Inc. – Are All Cardiovascular Cell Therapies Created Equal?

[Accesswire] – Pittsburgh, PA / May 5, 2014 / NeoStem, Inc. (NASDAQ: NBS) today published a new blog post on The Chairman’s Blog, written by the Company’s Chief Medical Officer Dr. Douglas W. Losordo. TheChairmansBlog.com … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here […]

NeoStem and Progenitor Cell Therapy (PCT) to Present at Multiple May Conferences

[GlobeNewswire] – NEW YORK — NeoStem, Inc. (NeoStem or the Company), a leader in the emerging cellular therapy industry, announced today that the Company and its subsidiary, Progenitor Cell Therapy, … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here to view […]

Nasdaq stocks posting largest percentage increases

[AP] – A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: InterCloud Systems rose 22.9 percent to $12.90. Bind Therapeutics rose 12.0 percent to $15.40. RiceBran Tech rose 10.6 percent … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click […]